This study successfully established a PTX-resistant breast cancer cell model, discovered the abnormal expression of multiple ABC transporters in it, and verified the necessity of co-inhibiting these ABC transporters for reversing MDR. This evidence concerns the gene ABCG2 and breast carcinoma.